CARLA WISE: Open Payments
NPI 1336768993 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 36 payments from 8 companies in 2025. Trend: 2023 $571 · 2024 $562 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $229 |
| Lilly USA, LLC | 3 | $136 |
| Alkermes, Inc. | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Amgen Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: ZEPBOUND, QULIPTA, UBRELVY, LYBALVI, LEQVIO, VRAYLAR, OTEZLA, VYEPTI.
Industry payments across IN — which companies pay providers there.
